[(1S,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl]diphenylphosphine
Aaron R. Van Dyke, Timothy F. Jamison
Abstract
Aaron R. Van Dyke, Timothy F. Jamison
Abstract
[43077-29-8] C22H29P (MW 324.44) InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m1/s1 InChIKey = BEYDOEXXFGNVRZ-COPCDDAFSA-N Phosphine, [(1R,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-, rel-[32511-22-1] InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m0/s1 InChIKey = BEYDOEXXFGNVRZ-VLCRHTCISA-N Phosphine, [(1R,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-[38053-73-5] InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m0/s1 InChIKey = BEYDOEXXFGNVRZ-VLCRHTCISA-N Phosphine, [(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-[43077-31-2] InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22-/m1/s1 InChIKey = BEYDOEXXFGNVRZ-BVYCBKJFSA-N (chiral monodentate phosphine ligand for asymmetric catalysis, resolution of organometallic complexes) Alternative Names: (+)-(S)-NMDPP; (+)-NMDPP; (+)-neomenthyldiphenylphosphine; (S)-neomenthyldiphenylphosphine; diphenyl-(+)-neomenthylphosphine; neomenthyldiphenylphosphine; d-neomenthyldiphenylphosphine. Physical Data: mp 98–99 °C; white crystalline solid. Solubility: soluble in EtOAc, THF, DMI, benzene, DCM, and CHCl3; slightly soluble in MeOH and EtOH. Form Supplied in: only the dextrorotatory antipode, (+)-NMDPP, is commercially available in variable levels of purity. Analysis of Reagent Purity: NMDPP oxide is a tenacious impurity and is assayed by 31P NMR (300 MHz, THF) δ: 33 (NMDPP oxide), −14.9 (NMDPP). Preparative Methods: NMDPP is prepared by the formation of diphenylphosphide from diphenylphosphine,1 diphenylphosphinous chloride,2 or triphenylphosphine,3 followed by alkylation with menthyl chloride or mesylate. (−)-Menthyldiphenylphosphine ((−)-MDPP), an epimer of (+)-NMDPP at C-1 of the menthyl ring, is prepared similarly by the displacement of neomenthylchloride with diphenylphosphide1a or, alternatively, by the displacement of diphenylphosphinous chloride with the Grignard reagent derived from menthyl chloride.4 Purification: recrystallized from MeOH or EtOH at reflux (degassed with N2) with rigorous exclusion of oxygen. Handling, Storage, and Precautions: oxygen must be excluded to avoid formation of the phosphine oxide; reagent is stable for extended periods when stored in a glovebox.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[43077-29-8] C22H29P (MW 324.44) InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m1/s1 InChIKey = BEYDOEXXFGNVRZ-COPCDDAFSA-N Phosphine, [(1R,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-, rel-[32511-22-1] InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m0/s1 InChIKey = BEYDOEXXFGNVRZ-VLCRHTCISA-N Phosphine, [(1R,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-[38053-73-5] InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m0/s1 InChIKey = BEYDOEXXFGNVRZ-VLCRHTCISA-N Phosphine, [(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-[43077-31-2] InChI = 1S/C22H29P/c1-17(2)21-15-14-18(3)16-22(21)23(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22-/m1/s1 InChIKey = BEYDOEXXFGNVRZ-BVYCBKJFSA-N (chiral monodentate phosphine ligand for asymmetric catalysis, resolution of organometallic complexes) Alternative Names: (+)-(S)-NMDPP; (+)-NMDPP; (+)-neomenthyldiphenylphosphine; (S)-neomenthyldiphenylphosphine; diphenyl-(+)-neomenthylphosphine; neomenthyldiphenylphosphine; d-neomenthyldiphenylphosphine. Physical Data: mp 98–99 °C; white crystalline solid. Solubility: soluble in EtOAc, THF, DMI, benzene, DCM, and CHCl3; slightly soluble in MeOH and EtOH. Form Supplied in: only the dextrorotatory antipode, (+)-NMDPP, is commercially available in variable levels of purity. Analysis of Reagent Purity: NMDPP oxide is a tenacious impurity and is assayed by 31P NMR (300 MHz, THF) δ: 33 (NMDPP oxide), −14.9 (NMDPP). Preparative Methods: NMDPP is prepared by the formation of diphenylphosphide from diphenylphosphine,1 diphenylphosphinous chloride,2 or triphenylphosphine,3 followed by alkylation with menthyl chloride or mesylate. (−)-Menthyldiphenylphosphine ((−)-MDPP), an epimer of (+)-NMDPP at C-1 of the menthyl ring, is prepared similarly by the displacement of neomenthylchloride with diphenylphosphide1a or, alternatively, by the displacement of diphenylphosphinous chloride with the Grignard reagent derived from menthyl chloride.4 Purification: recrystallized from MeOH or EtOH at reflux (degassed with N2) with rigorous exclusion of oxygen. Handling, Storage, and Precautions: oxygen must be excluded to avoid formation of the phosphine oxide; reagent is stable for extended periods when stored in a glovebox.
Key concepts: Phosphine, Chemistry, Denticity, Diphenylphosphine, Medicinal chemistry, Stereochemistry, Crystallography, Catalysis